Clinical Research Directory

Inclusion Criteria: * Both gender (men and women) will be selected, aged 45 year to 60 year. * Participants in the study who give their informed consent. * Participants whose BMI (Body Mass Index) is above 25.9 kg/m2 will be included. * Patients with positive Liver Fibrosis diagnosis will be selected. * Participants with Total Protein above or below the normal range of 6.0 and 8.3 g/dL will be included * Participants with ALT (Alanine Aminotransferase) above 5 to 40 U/L will be included * Participants with ALP (Alkaline Phosphatase) above 40 - 129 U/L will be included * Participants with AST (Aspartate Aminotransferase) above 10 - 50 U/L will be included * Participants serum GGT (Gamma-glutamyl Transferase) above 8 to 61 U/L will be included * Participants with CRP (C-Reactive Protein) above less than 1.0 mg/L will be included * Participants Serum Albumin below 3.4 to 5.4 g/dL will be included * Participants Total cholesterol above 240 mg/dL will be included * Participants with Vitamin D3 below 21-100 ng/mL will be included Exclusion Criteria: * Individuals who have a known allergy or have experienced any adverse reaction to prickly pear pulp powder or any of the ingredients used in the lozenges will not be included in the study. * Patients who are taking medications known to significantly alter fatty liver of other liver functions. * Individuals who have recently had liver transplant surgery or injury.